Investment Rating - The report indicates a positive outlook for European healthtech, highlighting a resilient venture capital funding environment and the emergence of consumer-focused healthtech unicorns [9][11]. Core Insights - The European healthtech sector is gaining momentum, particularly among consumer-focused companies, with notable unicorns like Cera, Huma, and Flo Health achieving a combined $430 million in venture funding [9]. - The overall venture capital funding in European and UK healthcare companies reached over $12.3 billion in 2024, marking the third-highest figure on record [11]. - The report emphasizes the importance of strategic partnerships between startups and large corporates, focusing on finding the right fit and developing meaningful return on investment metrics [8]. Summary by Sections Key Takeaways - Efficiency is a central theme, with companies aiming to achieve more with less, while large funding rounds may lead to inefficiencies [8]. - There is optimism regarding the potential for European companies to challenge US dominance in healthtech and life sciences, especially in light of shifting US trade policies [11]. Momentum for European Healthtech - The European venture ecosystem is forming the foundation for the next generation of consumer healthtech companies, contrasting with the US market's focus on B2B2C models [10]. - Notable funding rounds include Oura's $200 million round, elevating its valuation to $5.2 billion [9]. Spotlight on Women's Health - The report highlights the growing focus on women's health within the healthtech sector, although specific details are not provided in the extracted content. Appendix - The appendix includes a list of medtech startups showcased at the LSX World Congress, detailing their funding, valuations, and active investors [12][13].

Core Points - Premier Health of America Inc. held its annual general meeting on April 30, 2025, where all matters submitted for shareholder approval were approved [1][2] - Raymond Chabot Grant Thornton LLP was re-appointed as the auditor, and board members Pierre-Luc Toupin, Hubert Marleau, and Jean-Robert Pronovost were elected for the upcoming year [2] - The incentive Stock Option Plan of the Corporation was ratified and approved by shareholders [2] Voting Details - A total of 30,250,678 common shares were voted, representing 54.49% of the total shares issued and outstanding as of the record date [3] Company Overview - Premier Health is a leading Canadian Healthtech company that offers a comprehensive range of outsourced healthcare services to governments, corporations, and individuals [4] - The company utilizes its proprietary LiPHe platform to drive digital transformation in the healthcare services sector, aiming to provide faster, cheaper, and more accessible care services [4]

MONTRÉAL, March 27, 2025 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (the “Corporation”), a leading Canadian Healthtech company, announces that Martin Legault has resigned from his role as President and Chief Executive Officer of the Corporation, as well as from his position on the Board of Directors, effective as of March 27, 2025. The Corporation thanks Mr. Legault for his 22 years of service and leadership. Guy Daoust, the Chief Financial Officer of the Corporation, has been appointed ...